Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2019 06:55 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Launches New Corporate Website

PARSIPPANY, NJ, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (IDXG) announced today that it is launching its new corporate website, “Interpace.com”. Now both the Diagnostics and...
November 13, 2019 16:40 ET | Source: Interpace Biosciences, Inc.

Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results

Third Quarter Revenue Grew 34% Over the Prior Year’s Quarter and 25% Year to Date Acquired BioPharma Business in Partnership with Ampersand Diagnostic Test Volume Grew 16% for the Quarter and...
November 12, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019

PARSIPPANY, NJ, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will report its third quarter 2019 financial results on Wednesday, November 13, 2019 at 4:30 p.m. ET....
November 04, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Publication of New Data on Thyroid Test Utility

Clinical Data Highlights the Utility of ThyGeNEXT® and ThyraMIR® PARSIPPANY, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Interpace Group (NASDAQ: IDXG) Interpace Diagnostics announced today the...
October 29, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace to Present Data at the ATA Annual Meeting

PARSIPPANY, NJ, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will be presenting new data on the performance of its molecular thyroid products at the upcoming 89th...
October 24, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace to Present at the American College of Gastroenterology Conference

Interpace hosts 2nd Annual Fellow Programs PARSIPPANY, NJ, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will be presenting new data on the performance of its...
October 17, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners

PARSIPPANY, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand...
October 15, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Named to ‘Most Admired Companies’ List

PARSIPPANY, NJ, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has been named one of the 50 Most Admired Companies of the Year by The...
September 30, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans

In-Network Access for Thyroid Assays for More than 5 Million Members PARSIPPANY, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it...
September 18, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace to Present at The Ladenburg Thalmann 2019 Healthcare Conference

PARSIPPANY, NJ, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming...